Oncowitan logo (white)
  • About us
  • Our offer
    • Scientific writing & evaluation
    • Pharma projects
    • CDMO support
  • News
    • CDMO
    • Publications
  • [Gallery]

Gallery

News-Publications

New publication: A family of plant-derived products used in Chinese medicine to treat inflammatory diseases and COVID-19.

(more…)

By Christian Bailly, 3 years6 February 2022 ago
Gallery

Sargenor® (L-arginine aspartate), from Laboratoires Sarget (Paris), 1972

(more…)

By Christian Bailly, 3 years3 February 2022 ago
News-Publications

New publication: interaction of the natural product brazilin and derivatives with nuclear protein BAF1.

(more…)

By Christian Bailly, 3 years29 January 2022 ago
News-Publications

New publication: A series of anticancer agents isolated from the plant Inula japonica: the japonicones.

(more…)

By Christian Bailly, 3 years26 January 2022 ago
Gallery

Febrectol® (tetracycline, paracetamol, tripelennamine), from Laboratoire Solac (Toulouse, F), 1971

(more…)

By Christian Bailly, 3 years16 January 2022 ago
News-Publications

New publication: The anti-ulcer drug amlexanox can be useful to combat cancers.

(more…)

By Christian Bailly, 3 years7 January 2022 ago
Gallery

Athérolip® (clofibrate), from Laboratoires Solac (Toulouse), 1971

(more…)

By Christian Bailly, 3 years27 December 2021 ago
News-Publications

New publication: Lactose as a modulator of the immune checkpoint Gal-9/TIM-3

(more…)

By Christian Bailly, 3 years25 December 2021 ago
Gallery

Dihydroergotamine® (1-phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-n-butyl-pyrazolidine), from Laboratoires Sandoz (Nanterre), 1971

(more…)

By Christian Bailly, 3 years9 December 2021 ago
News-Publications

New publication: An antibacterial drug used in veterinary medicine, thiostrepton.

(more…)

By Christian Bailly, 3 years9 December 2021 ago

Posts navigation

Previous 1 … 12 13 14 … 25 Next
Search
  • Our partners
  • Contact
  • Legal notice
Hestia | Developed by ThemeIsle
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OK